Irving et al. have identified that NRAS mutations were associated with an increased risk of progression within hyperdiploidy standard-risk patient group by analyzing cytogenetic data from 427 children with relapsed B-ALL (Irving et al., 2016). The gene discussed is NRAS; the disease is acute lymphoblastic leukemia.